Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients
This study is ongoing, but not recruiting participants.
Study NCT00028314 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: December 20, 2001 Last Updated: November 3, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Lipodystrophy
Wasting Disease
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
Wasting Syndrome
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Lipid Metabolism Disorders
Metabolic Diseases
Nutrition Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Metabolic
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
Abacavir sulfate
Atazanavir/Ritonavir
Lopinavir/Ritonavir
Nevirapine
Additional drug interventions recognized in this trial
Abacavir
Atazanavir
Reverse Transcriptase Inhibitors
Ritonavir
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Back to top of Main Content
